Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01493817 · ClinicalTrials.gov registry record
Biomarkers in Samples From Younger Patients With Wilms Tumor
A clinical trial of Wilms Tumor and Other Childhood Kidney Tumors, sponsored by Children's Oncology Group.
- Completed
- Registry status
- 30
- Enrollment target
- 1
- Study location
NCT01493817: Completed study of Wilms Tumor and Other Childhood Kidney Tumors, sponsored by Children's Oncology Group.
NCT01493817 is a study of Wilms Tumor and Other Childhood Kidney Tumors that has completed, run by Children's Oncology Group. The registered enrollment target is 30 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01493817, a study of Wilms Tumor and Other Childhood Kidney Tumors, has completed, sponsored by Children's Oncology Group.
- COMPLETED
- Registry status
- 30 participants
- Enrollment target
- 1
- Study location
Study Summary
This research study is studying biomarkers in tissue samples from younger patients with Wilms tumor. Studying samples of tissue from patients with cancer in the laboratory may help doctors identify and learn more about biomarkers related to cancer. It may also help doctors predict how patients respond to treatment
Primary Outcome
Correlation of each type of macrophage score with tumor staging, presence of vascular invasion, and disease-free survival will be assessed.
Conditions Studied
Interventions
- OTHER laboratory biomarker analysis
Study Locations (1)
California
- Children's Oncology Group - Monrovia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2011-12 |
What the finished NCT01493817 record still lists
NCT01493817 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 30 participants, a relatively small participant target.
The record links to 1 condition, with Wilms Tumor and Other Childhood Kidney Tumors appearing as the primary indexed condition, and to 1 intervention - of which laboratory biomarker analysis is the first listed.
NCT01493817 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT01493817 about?
NCT01493817 is a clinical study titled "Biomarkers in Samples From Younger Patients With Wilms Tumor". This research study is studying biomarkers in tissue samples from younger patients with Wilms tumor. Studying samples of tissue from patients with cancer in the laboratory may help doctors identify and learn more about biomarkers related to cancer. It may also help doctors predict how patients respo...
What is the current status of trial NCT01493817?
This trial is currently completed. The enrollment target is 30 participants. The study started on 2011-12.
What conditions does trial NCT01493817 study?
This clinical trial studies the following conditions: Wilms Tumor and Other Childhood Kidney Tumors.
What interventions are being tested in trial NCT01493817?
The interventions under investigation include: laboratory biomarker analysis (OTHER).
Who is sponsoring clinical trial NCT01493817?
This trial is sponsored by Children's Oncology Group, which has 342 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01493817 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Wilms Tumor and Other Childhood Kidney Tumors
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia